When treatment stops mid-progress, the true cost isn't measured in dollars—it’s measured in lost potential.

The sudden removal of NDIS funding for neurofeedback on 3 October 2024 forced families to halt treatments that were showing real results. Parents report watching their children's progress slip away as they scramble to find alternatives, knowing that each day without effective treatment means hard-won gains could be lost. The impact ripples through every aspect of daily life, from school performance to family dynamics.

Switching therapies mid-stream creates a devastating setback that extends far beyond the immediate disruption.

For many autistic individuals, finding an effective treatment is a journey of trial and error. When neurofeedback finally offers breakthrough progress, having it stripped away doesn't just pause development—it risks regression. Families now face the heartbreaking choice between finding ways to privately fund their proven treatment or watching their loved ones struggle with less effective alternatives.

The NDIS decision ignores the compounding nature of developmental progress.

Each week of interrupted treatment doesn't just pause progress—it creates a widening gap that becomes increasingly difficult to bridge. The "savings" from cutting neurofeedback funding pale in comparison to the long-term costs of delayed development, increased support needs, and the potential need for more intensive interventions later.

Every day of disrupted treatment represents a missed opportunity for development that we can never get back.

The real cost of this funding cut isn't just financial—it’s the lost potential of individuals who were finally making breakthrough progress with neurofeedback. We must restore funding before more families watch years of progress slip away, creating costs that will far exceed any short-term savings.